OraSure Technologies, Inc. (NASDAQ:OSUR) was a big mover last session, as the company saw its shares jump a little above 10% on the day. The move came after the announcement of a latest agreement with Bill & Melinda Gates Foundation to support the reasonably priced sales of its OraQuick HIV Self-Test in 50 developing countries. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 14% in the past one-month time frame.
The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
OraSure Technologies currently holds a Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%.
OraSure Technologies, Inc. Price
Another top-ranked stock in the Medical - Products industry is Lantheus Holdings, Inc. (NASDAQ:LNTH) sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is OSUR going up? Or down? Predict to see what others think: Up or Down
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>
OraSure Technologies, Inc. (OSUR): Free Stock Analysis Report
Lantheus Holdings, Inc. (LNTH): Free Stock Analysis Report
Original post
Zacks Investment Research